Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000891293-11-000001
Filing Date
2011-01-03
Accepted
2011-01-03 19:02:19
Documents
1
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 13738
  Complete submission text file 0000891293-11-000001.txt   15530
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Issuer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SPACELABS MEDICAL INC 15220 NE 40TH ST REDMOND WA 98053
Business Address
NUDELMAN PHILLIP M PHD (Reporting) CIK: 0001041084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 11503025